In vitro and in vivo experiments confirmed its ability to reduce ribonuclear foci and partially rescue misregulated splicing of cardiac troponin T (cTNT) and insulin receptor (IR), two preRNAs mis-spliced in the DM1 context. Here, TNNT2 is linked to myotonic dystrophy type 1.